Diagnostic yield of screening for type 2 diabetes in high-risk patients: A systematic review

Journal of Family Practice

Volumn 48, Issue 10, 1999, Pages 805-810

  Rao, Goutham ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Diabetes mellitus, non insulin dependent; Mass screening; Review literature

Indexed keywords

BLOOD; CROSS-SECTIONAL STUDY; EVIDENCE BASED MEDICINE; GLUCOSE BLOOD LEVEL; HUMAN; MASS SCREENING; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; REPRODUCIBILITY; REVIEW; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; STATISTICS;

BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; EVIDENCE-BASED MEDICINE; HUMANS; LIKELIHOOD FUNCTIONS; MASS SCREENING; MODELS, STATISTICAL; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS;

EID: 0033203705     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. American Diabetes Association. Direct and indirect costs of diabetes in the United States in 1993. Alexandria, Va: American Diabetes Association; 1993.
2. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the third national health and nutrition examination survey, 1988-1994. Diabetes Care 1998; 21:518-24.
3. Worrall G. Screening healthy people for diabetes: is it worthwhile? J Fam Pract 1991; 33:155-60.
4. Newman WP, Nelson R, Scheer K. Community screening for diabetes. Low detection rate in a low-risk population. Diabetes Care 1994; 17:363-5.
5. Bourn D, Mann J. Screening for noninsulin dependent diabetes mellitus and impaired glucose tolerance in a Dunedin general practice: is it worth it? NZ Med J 1992; 105:207-10.
6. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 1998; 21(suppl 1):S20-2.
7. Paterson R. Population screening for diabetes mellitus. Diabet Med 1993; 10:777-81.
8. World Health Organization Study Group on Prevention of Diabetes Mellitus. Prevention of diabetes mellitus. Geneva, Switzerland: World Health Organization; 1994 (Technical Report Series, no. 844).
9. US Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore, Md: Williams & Wilkins; 1996.
10. Canadian Task Force on the Periodic Health Examination. The periodic health examination. Can Med Assoc J 1979; 121:1193-254.
11. Jaeschke R, Guyatt G, Sackett DL. Users' guide to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? JAMA 1994; 271:389-91.
12. Duncan WE, Linville N, Clement S. Assessing risk factors when screening for diabetes mellitus. Diabetes Care 1993; 16:1403-4.
13. American Diabetes Association. Are you at risk for diabetes? Diabetes Forecast 1993; 46:55.
14. McGregor MS, Pinkham C, Ahroni JH, Herter CD, Doctor JD. The American Diabetes Association risk test for diabetes: is it a useful screening tool? Diabetes Care 1995; 18:585-6.
15. Burden ML, Burden AC. The American Diabetes Association screening questionnaire for diabetes: is it worthwhile in the U.K.? Diabetes Care 1994; 17:97-8.
16. Herman WH, Smith PJ, Thompson TJ, Engelgau MM, Aubert RE. A new and simple questionnaire to identify people at increased risk for undiagnosed diabetes. Diabetes Care 1995; 18:382-7.
17. National Center for Health Statistics. Plan and operation of the second national health and nutrition examination survey. Vital Health Stat 1 Washington, DC: US Government Printing Office; 1981 (Department of Health and Human Services publication no. 81-1317).
18. Barriga KJ, Hamman RF, Hoag S, Marshall JA, Shetterly SM. Population screening for glucose intolerant subjects using decision tree analysis. Diabetes Res Clin Pract 1996; 34(suppl):S17-29.
19. Azzopardi J, Fenech FF, Junoussov Z, Mazovetsky A, Olchanski V. A computerized health screening and follow-up system in diabetes mellitus. Diabet Med 1995; 12:271-6.
20. Ruige JB, De Neeling JND, Kostense PJ, Bouter LM, Heine RJ. Performance of an NIDDM screening questionnaire based on symptoms and risk factors. Diabetes Care 1997; 20:491-6.
21. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352:837-53.
22. Jaeschke R, Guyatt G, Sackett DL. Users' guide to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? JAMA 1994; 271:703-7.